PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11392533-4	2001	The present study was undertaken to examine the general utility of AzaTyr as a structural motif for PTP inhibitor design by examining the phospho-azatyrosine (pAzaTyr)-containing peptide Ac-Asp-Ala-Asp-Glu-pAzaTyr-Leu-amide (8) in a PTP1 enzyme system.	beta-(5-hydroxy-2-pyridyl)alanine	67-73	protein tyrosine phosphatase receptor type U	Homo sapiens	100-103	
11392533-7	2001	The much lower PTP affinity of the pAzaTyr-containing peptide reduces the potential utility of the AzaTyr pharmacophore for PTP inhibitor design.	beta-(5-hydroxy-2-pyridyl)alanine	36-42	protein tyrosine phosphatase receptor type U	Homo sapiens	15-18	
11392533-7	2001	The much lower PTP affinity of the pAzaTyr-containing peptide reduces the potential utility of the AzaTyr pharmacophore for PTP inhibitor design.	beta-(5-hydroxy-2-pyridyl)alanine	36-42	protein tyrosine phosphatase receptor type U	Homo sapiens	124-127